Anavex Life Sciences Corp (AVXL)

[falconer66a]

Yes, why the late-date inclusion of Anavex?

But anything exceptionally important would not be held to a hard deadline by the conference organizers.

It appears that Anavex's Parkinson's disease dementia clinical results got included in the big CTAD event at the last moment. It's strange enough that the Alzheimer's people would invite and allow a Parkinson's presentation at their big annual event. Then, as "late-braking" news.

Doubtless, when the Alzheimer's people saw the blarcamesine data they were blown away. They would have never included them if they were weak or moderate. Instead, they displayed a new CNS disease treatment paradigm; one that actually works. So very rare for CNS diseases.

But another reason they included Anavex is this.

I've traveled across much of North America to attend (and present in) international science conferences, in my area of specialty (which is not medicine). Lots of dead time in travel, in hotel rooms, etc. Sure, all the really top-line people attend these conferences, and lots things are learned and shared. But, in fact, a lot (well, the majority) of the presentations are merely incremental in the progression of the discipline's relevant body of knowledge. Usually, good enough. But nothing to write home about. One often wonders, was it worth coming to this conference?

This year's CTAD conference? Let's watch to see what the media report on it. Wanna bet it'll be something about the dementia of Parkinson's disease, and some new drug that now has great promise for the dementias of all of the CNS disease?

Everyone in the audience listening to the presentation will remember it intently. Years from now, they will tell professional friends, "Yes, back in 2020 I was at that CTAD conference; heard the Anavex presentation, when for the first time the world learned of blarcamesine. Was an honor to be there."